Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ziopharm Oncology buy DomRuinart

Ziopharm Oncology
Start price
€2.44
31.05.21 / 50%
Target price
€4.00
31.05.22
Performance (%)
-2.46%
End price
€2.38
07.06.21
Summary
This prediction ended on 07.06.21 with a price of €2.38. With a performance of -2.46%, the BUY prediction by DomRuinart finished with a loss. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Ziopharm Oncology - - -
iShares Core DAX® 2.112% -0.367% 13.466%
iShares Nasdaq 100 -2.197% -3.794% 38.426%
iShares Nikkei 225® -1.555% -7.320% 18.451%
iShares S&P 500 -0.472% -2.078% 27.488%

According to DomRuinart what are the pros and cons of Ziopharm Oncology for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Ziopharm Oncology diskutieren
Prediction Buy
Perf. (%) -2.46%
Target price 4.000
Change
Ends at 31.05.22

Buy mit Kursziel 4,0

DomRuinart 
0
Report Share
31.05.21
In the thread Trading Ziopharm Oncology
Prediction Buy
Perf. (%) -2.46%
Target price 4.000
Change
Ends at 31.05.22

Buy beendet

DomRuinart 
0
Report Share
07.06.21

Stopped prediction by DomRuinart for Ziopharm Oncology

buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.72
03.05.21
€5.00
03.05.22
-5.88%
17.05.21

Could be worthwhile Investment >10% per year
DomRuinart 
03.05.21 50%
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.62
19.04.21
€4.00
19.04.22
3.82%
03.05.21

Could be worthwhile Investment >10% per year
DomRuinart 
19.04.21 50%